Page last updated: 2024-12-07
g 1026
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
G 1026: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 133548 |
| CHEMBL ID | 1632119 |
| MeSH ID | M0111416 |
Synonyms (8)
| Synonym |
|---|
| benzamide, n-(4-chloro-3-(4-chlorobenzoyl)phenyl)-2-hydroxy-3,5-diiodo- |
| g-1026 , |
| AKOS001482760 |
| g 1026 |
| 80859-11-6 |
| n-[4-chloro-3-(4-chlorobenzoyl)phenyl]-2-hydroxy-3,5-diiodobenzamide |
| CHEMBL1632119 |
| DTXSID70230751 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (12)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID547928 | Antimicrobial activity against Pseudomonas aeruginosa ATCC 25619 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547942 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NTUH4722 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID548647 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547926 | Antimicrobial activity against Bacillus subtilis ATCC 23857 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547932 | Antimicrobial activity against Mycobacterium smegmatis BCRC 11565 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547930 | Antimicrobial activity against Stenotrophomonas maltophilia ATCC 13637 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547927 | Antimicrobial activity against Escherichia coli ATCC 29213 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547925 | Antimicrobial activity against oxacillin- and methicillin-resistant Staphylococcus aureus isolate Sa-OXA-R2 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547943 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547929 | Antimicrobial activity against Acinetobacter baumannii ATCC 49139 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547931 | Antimicrobial activity against Serratia marcescens ATCC 14756 after 18 to 24 hrs by alamar blue assay | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| AID547935 | Inhibition of transglycosylase assessed as inhibition of NBD- labelled lipid II polymerization | 2010 | Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24 | High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 23.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||